Literature DB >> 25869508

Des-aspartate angiotensin I (DAA-I) reduces endothelial dysfunction in the aorta of the spontaneously hypertensive rat through inhibition of angiotensin II-induced oxidative stress.

Wei Mee Loh1, Wei Chih Ling1, Dharmani D Murugan1, Yeh Siang Lau1, Francis I Achike2, Paul M Vanhoutte3, Mohd Rais Mustafa4.   

Abstract

Des-aspartate angiotensin I (DAA-I), an endogenous nonapeptide, counteracts several effects of angiotensin II on vascular tone. The aim of this study was to investigate the acute protective effect of DAA-I on endothelial function in the spontaneously hypertensive rat (SHR) as well as its effect on angiotensin II-induced contractions and oxidative stress. Aortic rings were incubated with DAA-I (0.1μM) for 30min prior to the assessment of angiotensin II-induced contractions (0.1nM-10μM) in WKY and SHR aortas. Total nitrate and nitrite levels were assessed using a colorimetric method and reactive oxygen species (ROS) were measured by dihydroethidium (DHE) fluorescence and lucigenin-enhanced chemiluminescence. The effect of DAA-I was also assessed against endothelium-dependent and -independent relaxations to acetylcholine and sodium nitroprusside, respectively. Angiotensin II-induced contractions were significantly reduced by DAA-I, losartan and tempol. Incubation with ODQ (soluble guanylyl cyclase inhibitor) and removal of the endothelium prevented the reduction of angiotensin II-induced contractions by DAA-I. Total nitrate and nitrite levels were increased in DAA-I, losartan and tempol treated-SHR tissues while ROS level was reduced by DAA-I and the latter inhibitors. In addition, DAA-I significantly improved the impaired acetylcholine-induced relaxation in SHR aortas whilst sodium nitroprusside-induced endothelium-independent relaxation remained unaffected. The present findings indicate that improvement of endothelial function by DAA-I in the SHR aorta is mediated through endothelium-dependent release of nitric oxide and inhibition of angiotensin II-induced oxidative stress.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DAA-I; Endothelial function; Hypertension; Nitric oxide; Renin–angiotensin system

Mesh:

Substances:

Year:  2015        PMID: 25869508     DOI: 10.1016/j.vph.2015.03.011

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  7 in total

1.  The Role of Cyclooxygenase Enzymes in the Effects of Losartan and Lisinopril on the Contractions of Rat Thoracic Aorta.

Authors:  Fikriye Yasemin Ozatik; Bilgin Kaygisiz; Kevser Erol
Journal:  Eurasian J Med       Date:  2017-02

2.  Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.

Authors:  Eva Gatineau; Ming C Gong; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

3.  Comment on: "A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-aspartate Angiotensin I in Healthy Subjects".

Authors:  Nuggehally R Srinivas
Journal:  Drugs R D       Date:  2017-03

4.  A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction.

Authors:  Ryo Watanabe; Jun-Ichi Suzuki; Kouji Wakayama; Yasuhiro Maejima; Munehisa Shimamura; Hiroshi Koriyama; Hironori Nakagami; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Ryuichi Morishita; Issei Komuro; Mitsuaki Isobe
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

5.  Sex Differences in the Vasodilation Mediated by G Protein-Coupled Estrogen Receptor (GPER) in Hypertensive Rats.

Authors:  Nathalie Tristão Banhos Delgado; Wender do Nascimento Rouver; Leandro Ceotto Freitas-Lima; Ildernandes Vieira-Alves; Virgínia Soares Lemos; Roger Lyrio Dos Santos
Journal:  Front Physiol       Date:  2021-07-29       Impact factor: 4.566

6.  Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat.

Authors:  Rosemary Wangensteen; Manuel Gómez-Guzmán; Inmaculada Banegas; Isabel Rodríguez-Gómez; Rosario Jiménez; Juan Duarte; Joaquín García-Estañ; Félix Vargas
Journal:  Biomedicines       Date:  2022-05-25

7.  Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation.

Authors:  Kalaivani Batumalaie; Muhammad Arif Amin; Dharmani Devi Murugan; Munavvar Zubaid Abdul Sattar; Nor Azizan Abdullah
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.